Author

Marion Dufeu

Centre de Recherche en Cancérologie de Lyon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Assay:ATAC-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Assay:CUT&Tag· 1

Frequent Co-Authors

Anaïs EberhardtiD· 2 shared Félix BoiviniD· 2 shared Félix PhamiD· 2 shared Julie CarameliD· 2 shared Maxime GrimontiD· 2 shared Raphaël Schneider· 2 shared Simon DurandiD· 2 shared Stéphane DalleiD· 2 shared

Activity by Year

2024-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Anaïs EberhardtORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Spatial tumour-immune ecosystems shape the efficacy of anti-PD1 immunotherapy in primary cutaneous melanoma

Félix Pham, Marion Dufeu, Valentin Benboubker, Maxime Grimont, Amelie LHORISSON, Justine Berthet, Marie Donzel, Raphaël Schneider, Laurie Tonon, Anne‐Claire Doffin, Félix Boivin, Simon Durand, Bertrand Dubois, Jonathan Lopez, Christophe Caux, , Julie Caramel

This study maps spatial tumour-immune interactions in melanoma and identifies how their organization affects anti-PD1 therapy efficacy.

bioRxiv · Jul 7, 2025 · PreprintCancer Biology

The epigenetic regulator TRIM24 controls melanoma cell dedifferentiation and resistance to treatment in melanoma

Simon Durand, Félix Boivin, Roxane M. Pommier, Laetitia Barbollat‐Boutrand, Maxime Grimont, Félix Pham, Marion Dufeu, Eric Cumunel, Raphaël Schneider, Anthony Ferrari, Anaïs Eberhardt, Stéphane Dalle, Julie Caramel

This study identifies TRIM24 as an epigenetic regulator that promotes melanoma cell dedifferentiation and treatment resistance, with potential as a druggable target.

bioRxiv · May 20, 2025 · PreprintCancer Biology

Modeling relaxation experiments with a mechanistic model of gene expression

Maxime Estavoyer, Marion Dufeu, Grégoire Ranson, Sylvain Lefort, Thibault Voeltzel, Véronique Maguer‐Satta, Olivier Gandrillon, Thomas Lepoutre

The paper models relaxation experiments using a mechanistic gene expression model with a proliferation term, showing good agreement with experimental data on CD34 antigen distribution.

BMC Bioinformatics · Aug 20, 2024Peer-reviewedSystems Biology